Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure
2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview
Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy: 5-year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial
Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes